Literature DB >> 23996222

Nitrous oxide induced myeloneuropathy: a case report.

Matt Rheinboldt1, Derrick Harper, David Parrish, Kirenza Francis, John Blase.   

Abstract

We report the case of a 35-year-old male with a history of chronic, escalating nitrous oxide abuse who presented to the ER with a history of recent onset generalized weakness, altered sensorium, abnormal posturing of the hands, urinary complaints, and decreased balance. Physical examination was notable for pathologically brisk reflexes in all extremities, generalized flexion contracture of the fingers, decreased sensation in a stocking and glove distribution, and a weakly positive Babinski sign. The patient was noted to be a poor historian with decreased attention and concentration though otherwise generally alert and oriented. No discrete sensory level in the chest or trunk was detected, and the overall clinical appearance was felt to be most compatible with a mixed myeloneuropathic pattern of central and peripheral involvement. Laboratory findings were normal and noncontributory. Cervical spine MRI subsequently performed to rule out cord compression, intrinsic spinal cord mass, or demyelinating disease was notable for a long segment of increased T2 signal extending from C2-C3 to C6-C7 localizing to the dorsal columns of the cord in a typical "inverted V" fashion. No associated cord expansion was seen nor was there evidence of extrinsic compression; faint associated contrast enhancement was observed on post-gadolinium images. Further evaluation with nerve conduction velocity and electromyographic testing was deferred. Based on the exam findings, clinical history, and presentation, a diagnosis of nitrous oxide-related myeloneuropathy was made, and treatment with high-dose vitamin B12 supplementation was instituted. Recovery has been slow to date.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23996222     DOI: 10.1007/s10140-013-1152-6

Source DB:  PubMed          Journal:  Emerg Radiol        ISSN: 1070-3004


  12 in total

1.  Myelopathy and polyneuropathy caused by nitrous oxide toxicity: a case report.

Authors:  Chih-Kang Hsu; Yue-Quen Chen; Vei-Zen Lung; Sheng-Chuan His; Huan-Chu Lo; Hann-Yeh Shyu
Journal:  Am J Emerg Med       Date:  2011-12-12       Impact factor: 2.469

2.  Spinal MRI precedes clinical improvement in subacute combined degeneration with B12 deficiency.

Authors:  Peter Berlit; Adrian Ringelstein; Thomas Liebig
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

Review 3.  Potential outcome factors in subacute combined degeneration: review of observational studies.

Authors:  Olavo M Vasconcelos; Erika H Poehm; Robert J McCarter; William W Campbell; Zenaide M N Quezado
Journal:  J Gen Intern Med       Date:  2006-10       Impact factor: 5.128

4.  Reversible nitrous oxide-induced myeloneuropathy with pernicious anemia: case report and literature review.

Authors:  Mike A Singer; Christos Lazaridis; Sharon P Nations; Gil I Wolfe
Journal:  Muscle Nerve       Date:  2008-01       Impact factor: 3.217

5.  Spinal MRI in vacuolar myelopathy, and correlation with histopathological findings.

Authors:  S Sartoretti-Schefer; T Blättler; W Wichmann
Journal:  Neuroradiology       Date:  1997-12       Impact factor: 2.804

6.  Magnetic resonance imaging of the spinal cord in a man with tabes dorsalis.

Authors:  Sanjay Pandey
Journal:  J Spinal Cord Med       Date:  2011-11       Impact factor: 1.985

7.  Severe myeloneuropathy from acute high-dose nitrous oxide (N2O) abuse.

Authors:  Rachel S Alt; Ryan P Morrissey; Maureen A Gang; Robert S Hoffman; Herbert H Schaumburg
Journal:  J Emerg Med       Date:  2010-06-07       Impact factor: 1.484

8.  Methionine in the treatment of nitrous-oxide-induced neuropathy and myeloneuropathy.

Authors:  C B Stacy; A Di Rocco; R J Gould
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

9.  Myeloneuropathy from nitrous oxide abuse: unusually high methylmalonic acid and homocysteine levels.

Authors:  Andrew J Waclawik; Christopher C Luzzio; Katalin Juhasz-Pocsine; Valerie Hamilton
Journal:  WMJ       Date:  2003

Review 10.  Copper deficiency myelopathy.

Authors:  Stephan R Jaiser; Gavin P Winston
Journal:  J Neurol       Date:  2010-03-16       Impact factor: 4.849

View more
  2 in total

1.  Hyperbaric oxygen therapy to improve cognitive dysfunction and encephalatrophy induced by N2O for recreational use: a case report.

Authors:  Dan Luo; Jiajun Xu; Li Hu; Liangming Yu; Leling Xie; Jing Li
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-03       Impact factor: 2.570

2.  Subacute Combined Spinal Cord Degeneration by Recreational Laughing Gas (N2O) Use.

Authors:  Marthe R Onrust; Stephan Tfm Frequin
Journal:  J Cent Nerv Syst Dis       Date:  2019-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.